Attached files
| file | filename |
|---|---|
| EX-5.1 - OPINION OF FENWICK & WEST LLP - Audentes Therapeutics, Inc. | d307713dex51.htm |
| EX-1.1 - FORM OF UNDERWRITING AGREEMENT - Audentes Therapeutics, Inc. | d307713dex11.htm |
| S-1/A - S-1/A - Audentes Therapeutics, Inc. | d307713ds1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Audentes Therapeutics, Inc.:
We consent to the use of our report incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
April 14, 2017